Targeting biomolecular condensation and protein aggregation against cancer

JL Silva, D Foguel, VF Ferreira, TCRG Vieira… - Chemical …, 2023 - ACS Publications
Biomolecular condensates, membrane-less entities arising from liquid–liquid phase
separation, hold dichotomous roles in health and disease. Alongside their physiological …

Cervical cancer immunotherapy: facts and hopes

L Ferrall, KY Lin, RBS Roden, CF Hung, TC Wu - Clinical Cancer Research, 2021 - AACR
It is a sad fact that despite being almost completely preventable through human
papillomavirus (HPV) vaccination and screening, cervical cancer remains the fourth most …

Combining immune checkpoint blockade and tumor-specific vaccine for patients with incurable human papillomavirus 16–related cancer: a phase 2 clinical trial

E Massarelli, W William, F Johnson, M Kies… - JAMA …, 2019 - jamanetwork.com
Importance In recurrent human papilloma virus (HPV)–driven cancer, immune checkpoint
blockade with anti–programmed cell death 1 (PD-1) antibodies produces tumor regression …

Dendritic cell-based immunotherapy

RL Sabado, S Balan, N Bhardwaj - Cell research, 2017 - nature.com
Immunotherapy using dendritic cell (DC)-based vaccination is an approved approach for
harnessing the potential of a patient's own immune system to eliminate tumor cells in …

Recent progresses in phototherapy‐synergized cancer immunotherapy

CW Ng, J Li, K Pu - Advanced Functional Materials, 2018 - Wiley Online Library
Cancer immunotherapy has recently gained much attention in the search of cancer cure due
to its ability to “train” the immune system in seeking out and removing residual tumor cells …

Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer

S Stevanović, A Pasetto, SR Helman, JJ Gartner… - Science, 2017 - science.org
Immunotherapy has clinical activity in certain virally associated cancers. However, the tumor
antigens targeted in successful treatments remain poorly defined. We used a personalized …

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia

GG Kenter, MJP Welters, ARPM Valentijn… - … England Journal of …, 2009 - Mass Medical Soc
Background Vulvar intraepithelial neoplasia is a chronic disorder caused by high-risk types
of human papillomavirus (HPV), most commonly HPV type 16 (HPV-16). Spontaneous …

Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion

Y Hailemichael, Z Dai, N Jaffarzad, Y Ye, MA Medina… - Nature medicine, 2013 - nature.com
To understand why cancer vaccine–induced T cells often do not eradicate tumors, we
studied immune responses in mice vaccinated with gp100 melanoma peptide in incomplete …

Therapeutic vaccines for HPV-associated malignancies

C Smalley Rumfield, N Roller, ST Pellom… - ImmunoTargets and …, 2020 - Taylor & Francis
Human papillomavirus (HPV)-related malignancies are responsible for almost all cases of
cervical cancer in women, and over 50% of all cases of head and neck carcinoma …

Cancer vaccines

LH Butterfield - Bmj, 2015 - bmj.com
Cancer vaccines are designed to promote tumor specific immune responses, particularly
cytotoxic CD8 positive T cells that are specific to tumor antigens. The earliest vaccines …